Intratumoral immunosuppression profiles in 11q‐deleted neuroblastomas provide new potential therapeutic targets

High‐risk neuroblastoma (NB) patients with 11q deletion frequently undergo late but consecutive relapse cycles with fatal outcome. To date, no actionable targets to improve current multimodal treatment have been identified. We analyzed immune microenvironment and genetic profiles of high‐risk NB cor...

Descripción completa

Detalles Bibliográficos
Autores principales: Coronado, Esther, Yañez, Yania, Vidal, Enrique, Rubio, Luis, Vera‐Sempere, Francisco, Cañada‐Martínez, Antonio José, Panadero, Joaquín, Cañete, Adela, Ladenstein, Ruth, Castel, Victoria, Font de Mora, Jaime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858123/
https://www.ncbi.nlm.nih.gov/pubmed/33252831
http://dx.doi.org/10.1002/1878-0261.12868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858123/
https://www.ncbi.nlm.nih.gov/pubmed/33252831
http://dx.doi.org/10.1002/1878-0261.12868

Ejemplares similares